US77313F1066
US77313F1066
Rocket Pharmaceuticals, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 228.516.000 | 273.205.000 | 16.4% | |
| Operating Income | -228.516.000 | -273.205.000 | 16.4% |
| Pretax Income | -223.123.000 | -258.746.000 | 13.8% |
| Net Income Common Stockholders | -223.123.000 | -258.746.000 | 13.8% |
| -- | -- | -- | |
| -- | -- | -- |